Dr. Martens (CHIX:DOCSL) Stock Based Compensation: £5.2 Mil (TTM As of Mar. 2026)


CHIX:DOCSL Dr. Martens PLC CHIX:DOCSL
52 GF Score
Price £0.72
GF Value £0.72
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dr. Martens Stock Based Compensation?

Dr. Martens CHIX:DOCSL +0.42% 52 Stock Based Compensation is £5.2 Mil as of Mar. 2026. GuruFocus rates CHIX:DOCSL with a GF Score™ of 52/100 and a GF Value™ of £0.72 (Fairly Valued). The stock has 3 warning signs investors should review.

Dr. Martens's Stock Based Compensation for the six months ended in Mar. 2026 was £1.2 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was £5.2 Mil.

Dr. Martens Stock Based Compensation Related Terms

Dr. Martens Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Dr. Martens's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Martens Stock Based Compensation Chart

Dr. Martens Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only 5.20 0.50 4.00 7.20 5.20

Dr. Martens Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.10 3.50 3.70 4.00 1.20
CHIX:DOCSL
52GF Score
Dr. Martens PLC CHIX:DOCSL
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Martens Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £5.2 Mil.

What does a Stock Based Compensation of £5.2 Mil mean?
Dr. Martens (CHIX:DOCSL) has a Stock Based Compensation of £5.2 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Dr. Martens and its competitors.
Is Dr. Martens' Stock Based Compensation too high?
Dr. Martens' current Stock Based Compensation is £5.2 Mil. Overall, Dr. Martens has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Stock Based Compensation compare to NKE and DECK?
Dr. Martens' Stock Based Compensation of £5.2 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Manufacturing - Apparel & Accessories company?
A good Stock Based Compensation depends on the Manufacturing - Apparel & Accessories industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Dr. Martens and its competitors. Dr. Martens's current Stock Based Compensation is £5.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (CHIX:DOCSL) is currently considered Fairly Valued. The stock's GF Value™ is £0.72, compared to a current price of £0.72 — trading 0.1% above its estimated fair value. The current Stock Based Compensation is £5.2 Mil. Dr. Martens' overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Dr. Martens (CHIX:DOCSL), the current Stock Based Compensation is £5.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Martens (CHIX:DOCSL) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Martens stock appears to be overvalued. The current stock price of £0.72 is trading 0.1% above its estimated GF Value™ of £0.72. GuruFocus considers Dr. Martens to be Fairly Valued.

Key valuation signals for CHIX:DOCSL:

  • Stock Based Compensation: £5.2 Mil
  • GF Value™: £0.72 vs. price of £0.72 (0.1% above fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the CHIX:DOCSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr. Martens Business Description

Address 28 Jamestown Road, Camden, London, GBR, NW1 7BY
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
52GF Score

Get the complete analysis for CHIX:DOCSL

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.72
Price
£0.72
GF Value